Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Onconetix (ONCO) Equity Ratio (2023 - 2025)

Historic Equity Ratio for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to 0.17.

  • Onconetix's Equity Ratio fell 7412.0% to 0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17, marking a year-over-year decrease of 7412.0%. This contributed to the annual value of 0.3 for FY2024, which is 178890.27% up from last year.
  • Per Onconetix's latest filing, its Equity Ratio stood at 0.17 for Q3 2025, which was down 7412.0% from 0.31 recorded in Q2 2025.
  • In the past 5 years, Onconetix's Equity Ratio registered a high of 0.88 during Q1 2023, and its lowest value of 0.48 during Q2 2024.
  • Over the past 3 years, Onconetix's median Equity Ratio value was 0.3 (recorded in 2024), while the average stood at 0.24.
  • Within the past 5 years, the most significant YoY rise in Onconetix's Equity Ratio was 178890.27% (2024), while the steepest drop was 20991.06% (2024).
  • Over the past 3 years, Onconetix's Equity Ratio (Quarter) stood at 0.02 in 2023, then soared by 1788.9% to 0.3 in 2024, then plummeted by 43.44% to 0.17 in 2025.
  • Its Equity Ratio was 0.17 in Q3 2025, compared to 0.31 in Q2 2025 and 0.21 in Q1 2025.